C4 Therapeutics, Inc. (CCCC) Earnings
|
Expand Research on CCCC
| Next EPS Date | 8/12/26 | EPS Growth Rate | +32.4% |
|---|---|---|---|
| Average EPS % Beat Rate | +10.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +0.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$0.25 | N/A | N/A | $7.72M | N/A | N/A | N/A | ||
| 5/12/26 |
Q126 | -$0.20 | -$0.25 | +$0.05 | $6.15M | $4.8M | N/A |  | | Details | |
| 2/26/26 |
Q425 | N/A | -$0.29 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 2/24/26 |
Q425 | N/A | -$0.29 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 2/23/26 |
Q425 | N/A | -$0.29 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 2/20/26 |
Q425 | N/A | -$0.29 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 2/19/26 |
Q425 | N/A | -$0.29 | N/A | N/A | $5.4M | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | -$0.44 | -$0.41 | -$0.03 | $11.23M | $6.13M | N/A | | | Details |
